相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association of Lipoprotein Subfractions and Coronary Artery Calcium In Patient at Intermediate Cardiovascular Risk
Borut Jug et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
Two Rare Variants Explain Association with Acute Myocardial Infarction in an Extended Genomic Region Including the Apolipoprotein(A) Gene
Werner Koch et al.
ANNALS OF HUMAN GENETICS (2013)
Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography
Maya S. Safarova et al.
ATHEROSCLEROSIS SUPPLEMENTS (2013)
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
Richard Haynes et al.
EUROPEAN HEART JOURNAL (2013)
Lipoprotein (a) is independently correlated with coronary artery calcification
Martin Greif et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2013)
Elevated lipoprotein (a), small apolipoprotein (a), and the risk of arterial ischemic stroke in North American children
Neil A. Goldenberg et al.
HAEMATOLOGICA (2013)
Lipoprotein(a): resurrected by genetics
F. Kronenberg et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Genetic Associations with Valvular Calcification and Aortic Stenosis
George Thanassoulis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Can Mediate Degradation of the Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1)
Maryssa Canuel et al.
PLOS ONE (2013)
Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis
Pia R. Kamstrup et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
FGF19 Signaling Cascade Suppresses APOA Gene Expression
Indumathi Chennamsetty et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Lipoprotein(a) and Risk of Coronary, Cerebrovascular, and Peripheral Artery Disease The EPIC-Norfolk Prospective Population Study
Deepti Gurdasani et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis
Yukihiko Momiyama et al.
ATHEROSCLEROSIS (2012)
In vivo stable-isotope kinetic study suggests intracellular assembly of lipoprotein(a)
Michael E. Frischmann et al.
ATHEROSCLEROSIS (2012)
Cost-Effectiveness Model of Use of Genetic Testing as an Aid in Assessing the Likely Benefit of Aspirin Therapy for Primary Prevention of Cardiovascular Disease
Dov Shiffman et al.
CLINICAL THERAPEUTICS (2012)
Lipoprotein(a): more interesting than ever after 50 years
Joseph B. Dube et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Emerging therapeutic agents to lower lipoprotein (a) levels
Brian Kolski et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Antisense oligonucleotides for the treatment of dyslipidaemia
Maartje E. Visser et al.
EUROPEAN HEART JOURNAL (2012)
Atorvastatin decreases lipoprotein(a): A meta-analysis of randomized trials
Hisato Takagi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2012)
Lipid-Related Markers and Cardiovascular Disease Prediction
Emanuele Di Angelantonio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Evidence of dependence of lipoprotein(a) on triglyceride and high-density lipoprotein metabolism
Matthew Konerman et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions
Rogier A. van Dijk et al.
JOURNAL OF LIPID RESEARCH (2012)
Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a)
Harshal A. Deshmukh et al.
JOURNAL OF LIPID RESEARCH (2012)
The PCSK9 decade
Gilles Lambert et al.
JOURNAL OF LIPID RESEARCH (2012)
Nicotinic acid inhibits hepatic APOA gene expression: studies in humans and in transgenic mice
Indumathi Chennamsetty et al.
JOURNAL OF LIPID RESEARCH (2012)
What Is the Role of Advanced Lipoprotein Analysis in Practice?
Jennifer G. Robinson
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Lipoprotein(a) as a Potential Causal Genetic Risk Factor of Cardiovascular Disease A Rationale for Increased Efforts to Understand its Pathophysiology and Develop Targeted Therapies
Sotirios Tsimikas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
Anna Helgadottir et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Lack of association between four SNPs in the SLC22A3-LPAL2-LPA gene cluster and coronary artery disease in a Chinese Han population: a case control study
Xiaofei Lv et al.
LIPIDS IN HEALTH AND DISEASE (2012)
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
Evan A. Stein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events
Adam Taleb et al.
BIOMARKERS IN MEDICINE (2011)
Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease
Yonghong Li et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2011)
Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women
Atif N. Qasim et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Effects of the CETP Inhibitor Evacetrapib Administered as Monotherapy or in Combination With Statins on HDL and LDL Cholesterol A Randomized Controlled Trial
Stephen J. Nicholls et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Farnesoid X receptor represses hepatic human APOA gene expression
Indumathi Chennamsetty et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Clinical utility of inflammatory markers and advanced lipoprotein testing: Advice from an expert panel of lipid specialists
Michael H. Davidson et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2011)
Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure
Guoqing Cao et al.
JOURNAL OF LIPID RESEARCH (2011)
Lipoprotein(a): Genotype-Phenotype Relationship and Impact on Atherogenic Risk
Byambaa Enkhmaa et al.
METABOLIC SYNDROME AND RELATED DISORDERS (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Genetic Variation in LPAL2, LPA, and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk
James Ronald et al.
STROKE (2011)
Atherogenic Lipids and Lipoproteins Trigger CD36-TLR2-Dependent Apoptosis in Macrophages Undergoing Endoplasmic Reticulum Stress
Tracie A. Seimon et al.
CELL METABOLISM (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
Management of Lp(a)
W. Virgil Brown et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
Oxidation-Specific Biomarkers, Lipoprotein(a), and Risk of Fatal and Nonfatal Coronary Events
Sotirios Tsimikas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Apolipoprotein(a) Isoforms and the Risk of Vascular Disease Systematic Review of 40 Studies Involving 58,000 Participants
Sebhat Erqou et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease.
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy
Daniel I. Chasman et al.
ATHEROSCLEROSIS (2009)
Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors Results From the Dallas Heart Study
Sotirios Tsimikas et al.
CIRCULATION (2009)
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Pia R. Kamstrup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Longitudinal cohort study on the effectiveness of lipid apheresis treatment to reduce high lipoprotein(a) levels and prevent major adverse coronary events
Beate R. Jaeger et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2009)
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Robert Clarke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Niacin and lipoprotein(a): Facts, uncertainties, and clinical considerations
Angelo M. Scanu et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Mechanism of action of niacin
Vaijinath S. Kamanna et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma
Claes Bergmark et al.
JOURNAL OF LIPID RESEARCH (2008)
The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2
Steve Poirier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase a2 activity, and 10-year cardiovascular outcomes - Prospective results from the Bruneck study
Stefan Kiechl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Catalysis of covalent Lp(a) assembly: Evidence for an extracellular enzyme activity that enhances disulfide bond formation
Lev Becker et al.
BIOCHEMISTRY (2006)
Lipoprotein(a) and apolipoprotein(a) isoforms - No association with coronary artery calcification in the Dallas Heart Study
R Guerra et al.
CIRCULATION (2005)
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol
ME Brousseau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models
MB Boffa et al.
CLINICAL BIOCHEMISTRY (2004)
Lack of association between lipoprotein(a) and coronary artery calcification in the Genetic Epidemiology Network of Arteriopathy (GENOA) Study
IJ Kullo et al.
MAYO CLINIC PROCEEDINGS (2004)
Lysine-phosphatidylcholine adducts in kringle V impart unique immunological and potential pro-inflammatory properties to human apolipoprotein(a)
C Edelstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Niacin and cholesterol: role in cardiovascular disease (Review)
SH Ganji et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2003)
Predictors of aortic and coronary artery calcium on a screening electron beam tomographic scan
P Raggi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Lipoprotein(a) enhances advanced atherosclerosis and vascular calcification in WHHL transgenic rabbits expressing human apolipoprotein(a)
HJ Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions - The Atherosclerosis Risk in Communities (ARIC) Study
AR Sharrett et al.
CIRCULATION (2001)
High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men
F Paultre et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
分享论文
